文献

J-GLOBAL ID：201302265990580055   整理番号：13A0781806

マイクロRNA-132は乳癌腺管内癌(DCIS)の多くでダウンレギュレーションとなり,細胞増殖阻害により腫瘍抑制性に作用

MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation

著者 (40件)： LI Shuai (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  ZHAI Lili (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  GU Feng (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  FAN Yu (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  LANG Ronggang (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  FU Li (Tianjin Medical Univ. Cancer Inst. and Hospital, Tianjin, CHN) ,  LI Shuai (Tianjin Medical Univ., Tianjin, CHN) ,  MENG Huimin (Tianjin Medical Univ., Tianjin, CHN) ,  ZHOU Feng (Tianjin Medical Univ., Tianjin, CHN) ,  ZHAI Lili (Tianjin Medical Univ., Tianjin, CHN) ,  ZHANG Lina (Tianjin Medical Univ., Tianjin, CHN) ,  GU Feng (Tianjin Medical Univ., Tianjin, CHN) ,  FAN Yu (Tianjin Medical Univ., Tianjin, CHN) ,  LANG Ronggang (Tianjin Medical Univ., Tianjin, CHN) ,  FU Li (Tianjin Medical Univ., Tianjin, CHN) ,  GU Lin (Tianjin Medical Univ., Tianjin, CHN) ,  QI Liqiang (Tianjin Medical Univ., Tianjin, CHN) ,  LI Shuai (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  MENG Huimin (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  ZHOU Feng (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  ZHAI Lili (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  ZHANG Lina (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  GU Feng (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  FAN Yu (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  LANG Ronggang (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  FU Li (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  GU Lin (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  QI Liqiang (Key Lab. of Cancer Prevention and Therapy, Tianjin, CHN) ,  LI Shuai (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  MENG Huimin (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  ZHOU Feng (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  ZHAI Lili (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  ZHANG Lina (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  GU Feng (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  FAN Yu (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  LANG Ronggang (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  FU Li (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  GU Lin (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  QI Liqiang (State Key Lab. of Breast Cancer Res., Tianjin, CHN) ,  FU Li (2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, CHN)
資料名： Pathology. Research and Practice  (Pathology. Research and Practice)
巻： 209  号： 3  ページ： 179-183  発行年： 2013年03月 
JST資料番号： A1139A  ISSN： 0344-0338  資料種別： 逐次刊行物 (A)
発行国： オランダ (NLD)  言語： 英語 (EN)

タイトルに関連する用語 (6件)： 乳癌 ,  腺管内癌 ,  DCIS ,  ダウンレギュレーション ,  細胞増殖阻害 ,  腫瘍抑制